ENTRY       D11913                      Drug
NAME        Oportuzumab monatox (USAN)
FORMULA     C3072H4731N877O952S12
EXACT_MASS  69523.5397
MOL_WEIGHT  69565.5192
SEQUENCE    HHHHHHDIQM TQSPSSLSAS VGDRVTITCR STKSLLHSNG ITYLYWYQQK PGKAPKLLIY
            QMSNLASGVP SRFSSSGSGT DFTLTISSLQ PEDFATYYCA QNLEIPRTFG QGTKVELKRA
            TPSHNSHQVP SAGGPTANSG TSGSEVQLVQ SGPGLVQPGG SVRISCAASG YTFTNYGMNW
            VKQAPGKGLE WMGWINTYTG ESTYADSFKG RFTFSLDTSA SAAYLQINSL RAEDTAVYYC
            ARFAIKGDYW GQGTLLTVSS EFGGAPEFPK PSTPPGSSGL EGGSLAALTA HQACHLPLET
            FTRHRQPRGW EQLEQCGYPV QRLVALYLAA RLSWNQVDQV IRNALASPGS GGDLGEAIRE
            QPEQARLALT LAAAESERFV RQGTGNDEAG AASADVVSLT CPVAAGECAG PADSGDALLE
            RNYPTGAEFL GDGGDVSFST RGTQNWTVER LLQAHRQLEE RGYVFVGYHG TFLEAAQSIV
            FGGVRARSQD LDAIWRGFYI AGDPALAYGY AQDQEPDARG RIRNGALLRV YVPRSSLPGF
            YRTGLTLAAP EAAGEVERLI GHPLPLRLDA ITGPEEEGGR LETILGWPLA ERTVVIPSAI
            PTDPRNVGGD LDPSSIPDKE QAISALPDYA SQPGKPPHHH HHHKDEL
            (Disulfide bridge: 29-99, 166-240, 294-316, 401-408)
  TYPE      Peptide
REMARK      ATC code: L01FX16
EFFICACY    Antineoplastic
  TYPE      Antibody-drug conjugate
COMMENT     Antibody-toxin conjugate
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
                L01FX Other monoclonal antibodies and antibody drug conjugates
                 L01FX16 Oportuzumab monatox
                  D11913  Oportuzumab monatox (USAN)
DBLINKS     CAS: 945228-48-8
///
